PDMR dealing and Total Voting Rights | 13-Dec-2023 | 16:54 | RNS |
G306 Phase III trial meets key endpoints | 13-Dec-2023 | 07:00 | RNS |
Update on funding | 11-Dec-2023 | 07:00 | RNS |
Total Voting Rights | 01-Dec-2023 | 07:00 | RNS |
Holding(s) in Company | 28-Nov-2023 | 15:03 | RNS |
G306 Grass Phase III trial meets primary endpoint | 14-Nov-2023 | 07:00 | RNS |
Form 8.5 (EPT/RI) | 10-Nov-2023 | 14:39 | RNS |
Director/PCA Dealing | 10-Nov-2023 | 13:22 | RNS |
Holding(s) in Company | 10-Nov-2023 | 13:11 | RNS |
Offer Closure | 10-Nov-2023 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 09-Nov-2023 | 10:48 | RNS |
Form 8.5 (EPT/RI) | 09-Nov-2023 | 09:24 | RNS |
Form 8.5 (EPT/NON-RI) | 09-Nov-2023 | 09:15 | RNS |
Form 8.5 (EPT/RI) | 08-Nov-2023 | 10:45 | RNS |
Form 8.5 (EPT/RI) | 07-Nov-2023 | 11:10 | RNS |
Currency | UK Pounds |
Share Price | 3.25p |
Change Today | -0.100p |
% Change | -2.99 % |
52 Week High | 6.25 |
52 Week Low | 0.88 |
Volume | 591,351 |
Shares Issued | 4,766.44m |
Market Cap | £154.91m |
RiskGrade | 268 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 34,261 @ 3.21p |
15:58 | 29,969 @ 3.31p |
14:00 | 5,000 @ 3.25p |
14:00 | 5,000 @ 3.25p |
13:04 | 49,000 @ 3.40p |
You are here: research